#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Role of sentinel node in breast cancer


Authors: M. Brychta
Authors‘ workplace: Radioterapeutická a onkologická klinika, 3. LF UK a FNKV, Praha 10, ČR
Published in: NuklMed 2015;4:2-3
Category: Editorial


Sources

1. Giuliano AE, Hunt KK, Ballman KV et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011;305:569-575

2. Galimberti V, Cole BF, Zurrida S et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol 2013;14:297–305

3. Gatzemeier W, Mann BG. Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND) – ACOSOG Z0011 results and beyond. Breast 2013;22:211-216

4. Morrow M, Giuliano AE. To cut is to cure: can we really apply Z11 in practice? Ann Surg Oncol 2011;9:2414–2415

5. Goldhirsch A, Wood WC, Coates AS et al. Panel members. Strategies for subtype – dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 2011;22:1736–1747

6. Goldhirsch A, Winer EP, Coates AS, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 2013;24:2206–2223

7. Šimánek M, Abrahám V, Hruška J. Indikace axilární disekce uzlin při nálezu mikrometastatického postižení sentinelové uzliny u karcinomu prsu. NuklMed 2015;1:4-7

Labels
Nuclear medicine Radiodiagnostics Radiotherapy
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#